Lemaitre Vascular (LMAT) Revenue (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Revenue data on file, last reported at $66.6 million in Q1 2026.

• On a quarterly basis, Revenue rose 11.16% year-over-year to $66.6 million in Q1 2026; TTM through Mar 2026 was $256.3 million, a 13.27% increase from a year earlier, with the FY2025 full-year figure at $249.6 million, up 13.53% from the prior year.
• Revenue for Q1 2026 stood at $66.6 million, up from $64.5 million in the prior quarter.
• Over the last five years, Revenue for LMAT reached as high as $66.6 million in Q1 2026 and fell as low as $39.0 million in Q3 2022.
• Historically, Revenue has averaged $52.4 million across 5 years, with a median of $53.5 million in 2024.
• Across the five-year window, Revenue increased 1.72% in 2022 and increased 21.48% in 2023, its largest moves.
• Year by year, Revenue stood at $41.0 million in 2022, then climbed by 19.36% to $48.9 million in 2023, then increased by 13.98% to $55.7 million in 2024, then climbed by 15.68% to $64.5 million in 2025, then grew by 3.26% to $66.6 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $66.6 million in Q1 2026, $64.5 million in Q4 2025, and $61.0 million in Q3 2025.